Free Trial

Collegium Pharmaceutical (COLL) SEC Filings & 10K Form

Collegium Pharmaceutical logo
$27.22 +0.16 (+0.59%)
As of 10:30 AM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Recent Collegium Pharmaceutical SEC Filings

DateFilerForm TypeView
04/28/2025
6:56 AM
BlackRock, Inc. (Filed by)
Collegium Pharmaceutical (Subject)
Form SCHEDULE 13G/A
03/24/2025
4:05 PM
Collegium Pharmaceutical (Issuer)
Dreyer Scott (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/24/2025
4:06 PM
Collegium Pharmaceutical (Issuer)
Tupper Colleen (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/21/2025
3:35 PM
Collegium Pharmaceutical (Subject)
Tupper Colleen (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/21/2025
3:21 PM
Collegium Pharmaceutical (Subject)
Dreyer Scott (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/20/2025
3:32 PM
Collegium Pharmaceutical (Subject)
Tupper Colleen (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/20/2025
3:17 PM
Collegium Pharmaceutical (Subject)
Dreyer Scott (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/20/2025
3:19 PM
Collegium Pharmaceutical (Subject)
Kuhlmann Shirley R. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/19/2025
3:34 PM
Collegium Pharmaceutical (Issuer)
Dieter David (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
03/19/2025
3:36 PM
Collegium Pharmaceutical (Issuer)
Dieter David (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/18/2025
6:18 PM
Collegium Pharmaceutical (Issuer)
Dreyer Scott (Reporting)
Form 4/A
03/18/2025
4:34 PM
Collegium Pharmaceutical (Issuer)
Dreyer Scott (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/18/2025
4:35 PM
Collegium Pharmaceutical (Issuer)
Tupper Colleen (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/17/2025
6:05 AM
Collegium Pharmaceutical (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/13/2025
3:49 PM
Collegium Pharmaceutical (Issuer)
Tupper Colleen (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/13/2025
3:50 PM
Collegium Pharmaceutical (Issuer)
Dreyer Scott (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/07/2025
3:13 PM
Collegium Pharmaceutical (Subject)
Tupper Colleen (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/06/2025
5:48 PM
Collegium Pharmaceutical (Issuer)
Kuhlmann Shirley R. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/06/2025
3:43 PM
Collegium Pharmaceutical (Subject)
Tupper Colleen (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/06/2025
3:05 PM
Collegium Pharmaceutical (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
03/06/2025
9:42 AM
Collegium Pharmaceutical (Subject)
Kuhlmann Shirley R. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/05/2025
2:03 PM
Collegium Pharmaceutical (Subject)
Kuhlmann Shirley R. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/27/2025
3:01 PM
Collegium Pharmaceutical (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/27/2025
3:03 PM
Collegium Pharmaceutical (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/07/2025
12:21 PM
Collegium Pharmaceutical (Subject)
Invesco Ltd. (Filed by)
Form SCHEDULE 13G
02/05/2025
4:30 PM
Collegium Pharmaceutical (Issuer)
Lurker Nancy (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
02/05/2025
4:30 PM
Collegium Pharmaceutical (Issuer)
Lurker Nancy (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/05/2025
7:05 AM
Collegium Pharmaceutical (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/14/2025
3:12 PM
Collegium Pharmaceutical (Issuer)
Kuhlmann Shirley R. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/08/2025
7:05 AM
Collegium Pharmaceutical (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/14/2024
3:50 PM
Collegium Pharmaceutical (Issuer)
Karnani Vikram (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/13/2024
4:13 PM
Collegium Pharmaceutical (Subject)
PRINCIPAL GLOBAL INVESTORS (Filed by)
Form SC 13G
11/13/2024
3:30 PM
Collegium Pharmaceutical (Subject)
Rubric Capital Management LP (Filed by)
Form SC 13G/A
11/13/2024
1:39 PM
Collegium Pharmaceutical (Subject)
RENAISSANCE TECHNOLOGIES LLC (Filed by)
Form SCHEDULE 13G
09/17/2024
3:32 PM
Collegium Pharmaceutical (Issuer)
Smith Thomas B (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/13/2024
9:39 AM
Collegium Pharmaceutical (Subject)
Smith Thomas B (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/13/2024
9:06 AM
Collegium Pharmaceutical (Subject)
Smith Thomas B (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/06/2024
4:52 PM
Collegium Pharmaceutical (Issuer)
Kuhlmann Shirley R. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/06/2024
10:53 AM
Collegium Pharmaceutical (Subject)
Kuhlmann Shirley R. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/05/2024
3:47 PM
Collegium Pharmaceutical (Subject)
Kuhlmann Shirley R. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/04/2024
7:03 AM
Collegium Pharmaceutical (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
The next market Nvidia is positioned to dominate … (Ad)

Robots — built by Nvidia. Forbes says this could be " a $24 trillion opportunity for investors." Huang said, "The ChatGPT moment for robotics is right around the corner." In fact, I believe these robots could impact 65 million Americans lives — this year. And one stock — currently priced around $7 — could be the biggest winner.

To see a live demonstration with one of these robots, simply click here.
08/12/2024
1:41 PM
Collegium Pharmaceutical (Subject)
McFarlane Neil F. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/09/2024
3:34 PM
Collegium Pharmaceutical (Subject)
McFarlane Neil F. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/29/2024
5:02 AM
Collegium Pharmaceutical (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/13/2024
7:05 AM
Collegium Pharmaceutical (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/05/2024
3:50 PM
Ciaffoni Joseph (Reporting)
Collegium Pharmaceutical (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/04/2024
3:36 PM
Ciaffoni Joseph (Reporting)
Collegium Pharmaceutical (Subject)
Collegium Pharmaceutical (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/03/2024
4:22 PM
Ciaffoni Joseph (Reporting)
Collegium Pharmaceutical (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/03/2024
12:59 PM
Collegium Pharmaceutical (Subject)
Kuhlmann Shirley R. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/30/2024
12:11 PM
Ciaffoni Joseph (Reporting)
Collegium Pharmaceutical (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/29/2024
10:19 AM
Ciaffoni Joseph (Reporting)
Collegium Pharmaceutical (Subject)
Form 144/A
05/29/2024
9:05 AM
Ciaffoni Joseph (Reporting)
Collegium Pharmaceutical (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/28/2024
3:22 PM
Collegium Pharmaceutical (Issuer)
Dreyer Scott (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/28/2024
11:12 AM
Collegium Pharmaceutical (Subject)
Tupper Colleen (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/28/2024
9:05 AM
Ciaffoni Joseph (Reporting)
Collegium Pharmaceutical (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/24/2024
3:05 PM
Collegium Pharmaceutical (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/24/2024
12:01 PM
Collegium Pharmaceutical (Subject)
Dreyer Scott (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/16/2024
6:20 PM
BOHLIN GAREN G (Reporting)
Collegium Pharmaceutical (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/16/2024
6:21 PM
Collegium Pharmaceutical (Issuer)
Heffernan Michael Thomas (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/16/2024
6:22 PM
Balice-Gordon Rita J. (Reporting)
Collegium Pharmaceutical (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/16/2024
6:22 PM
Collegium Pharmaceutical (Issuer)
Fallon John A. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/16/2024
6:22 PM
Collegium Pharmaceutical (Issuer)
Freund John Gordon (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/16/2024
6:23 PM
Collegium Pharmaceutical (Issuer)
McFarlane Neil F. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/16/2024
6:23 PM
Collegium Pharmaceutical (Issuer)
Melincoff Gwen A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/16/2024
6:23 PM
Collegium Pharmaceutical (Issuer)
SANTINI GINO (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/14/2024
2:12 PM
BOHLIN GAREN G (Reporting)
Collegium Pharmaceutical (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/13/2024
7:05 AM
Collegium Pharmaceutical (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/10/2024
7:02 AM
Collegium Pharmaceutical (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/10/2024
7:03 AM
Collegium Pharmaceutical (Filer)
Form DEFA14A
05/09/2024
3:07 PM
Collegium Pharmaceutical (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:COLL) was last updated on 5/2/2025 by MarketBeat.com Staff
From Our Partners